Kamada (KMDA) has released an update.
Kamada Ltd., a key player in the biopharmaceutical field, will present a corporate overview at the Stifel 2024 Healthcare Conference in New York. CEO Amir London will also be available for investor meetings, highlighting the company’s focus on growth and their extensive portfolio of plasma-derived products. Interested investors can access the live webcast through Kamada’s website.
For further insights into KMDA stock, check out TipRanks’ Stock Analysis page.